Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
5.32
+0.22 (4.31%)
At close: Apr 28, 2026, 4:00 PM EDT
5.25
-0.07 (-1.31%)
Pre-market: Apr 29, 2026, 6:29 AM EDT
Enveric Biosciences Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +2,155.64% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $1,800 | Strong Buy | Initiates | $1,800 | +33,734.59% | Jan 30, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $11,250 | Strong Buy | Initiates | $11,250 | +211,366.17% | Jun 1, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy → Hold Downgrades $63,000 → $1,800 | Strong Buy → Hold | Downgrades | $63,000 → $1,800 | +33,734.59% | Mar 8, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates $63,000 | Strong Buy | Initiates | $63,000 | +1,184,110.53% | Jul 8, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $54,000 | Strong Buy | Initiates | $54,000 | +1,014,937.59% | Jun 28, 2021 |